NW-3509A
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NW-3509A, covering 2017-03-14 to 2017-03-14. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Determine the Safety, Tolerability and Efficacy NW-3509A in Patients With Chronic Schizophrenia [Phase 2]